Stockscreener 앱 받기
24.60
3.61%
-0.92
Castle Biosciences Inc 주식(CSTL)의 최신 뉴스
Wall Street Analysts Predict an 85.15% Upside in Castle Biosciences (CSTL): Here's What You Should Know - Yahoo Finance Singapore
Free skin cancer screenings roll out nationwide with Castle support - Stock Titan
Castle Biosciences to present new Mayo Clinic research on TissueCypher test at Digestive Disease Week - Traders Union
Mayo Clinic data: Barrett's test changed surveillance in 55% - Stock Titan
Castle Biosciences, Inc. $CSTL Shares Sold by AIGH Capital Management LLC - MarketBeat
(CSTL) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
Earnings Preview: CSTL to Report Financial Results Post-market on May 06 - Moomoo
Castle Biosciences (NASDAQ:CSTL) Upgraded to Strong-Buy at Zacks Research - MarketBeat
Castle Biosciences (CSTL) to Release Earnings on Wednesday - MarketBeat
What makes Castle Biosciences (CSTL) a good fit for 'trend investing' - MSN
Castle Biosciences (NASDAQ:CSTL) Shares Gap Down on Insider Selling - MarketBeat
Castle Biosciences to Release First Quarter 2026 Financial Resul - GuruFocus
Castle Biosciences CEO Maetzold sells $104,708 in shares By Investing.com - Investing.com Australia
Castle Biosciences (NASDAQ:CSTL) Insider Sells $90,912.20 in Stock - MarketBeat
Castle Biosciences (NASDAQ: CSTL) CEO sells 4,172 shares via trusts - Stock Titan
CSTL (Castle Biosciences Inc.) reports narrower than expected Q4 2025 loss and slight revenue growth, lifting shares modestly.Open Stock Signal Network - Cổng thông tin điện tử tỉnh Tây Ninh
Castle Biosciences to Present New Data Demonstrating DecisionDx®-Melanoma's Ability to Identify Patients with Greater Risk of Recurrence and Poor Outcomes Within Early-Stage Melanoma at EADO and ACMS - The Malaysian Reserve
Castle Biosciences to present melanoma test data at conferences By Investing.com - Investing.com India
Castle Biosciences to present melanoma test data at conferences - Investing.com
New data suggest some early melanomas carry higher relapse risk - Stock Titan
Laboratory teams drive progress in skin cancer diagnostics at Castle Biosciences - Traders Union
CSTL Maintained by Canaccord Genuity -- Price Target Lowered to $40 - GuruFocus
(CSTL) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Castle Biosciences, Inc. (CSTL) Stock Analysis: A 97% Upside Potential Beckons Investors - DirectorsTalk Interviews
Castle Biosciences, Inc. (NASDAQ:CSTL) Given Consensus Recommendation of "Moderate Buy" by Analysts - MarketBeat
Castle Biosciences to Release First Quarter 2026 Financial Results and Host Webcast on Wednesday, May 6, 2026 - Sahm
Castle Biosciences inks expansion at Nova Place - WPXI
After the close on May 6, Castle Biosciences will break down Q1 - Stock Titan
Castle Biosciences inks expansion at Nova Place on North SidePittsburgh Business Times - The Business Journals
Aug EndMonth: How sensitive is Castle Biosciences Inc to inflationShare Buyback & AI Enhanced Trading Signals - baoquankhu1.vn
Castle Biosciences (NASDAQ:CSTL) Shares Down 7%What's Next? - MarketBeat
Castle Biosciences Earns 2026 USA TODAY Top Workplaces Award for Fifth Consecutive Year - Bitget
Castle Biosciences, Inc.Common stock (NQ: CSTL - The Chronicle-Journal
Castle Biosciences CEO sells shares worth $246,195 By Investing.com - Investing.com Australia
Breakouts Watch: Does Castle Biosciences Inc have declining or rising EPSEarnings Miss & Fast Gain Swing Alerts - baoquankhu1.vn
Ideas Watch: Can Castle Biosciences Inc deliver alphaWeekly Trade Report & AI Forecasted Stock Moves - baoquankhu1.vn
Insider Selling: Castle Biosciences (NASDAQ:CSTL) Insider Sells 6,214 Shares of Stock - MarketBeat
Castle Biosciences CEO sells shares worth $246,195 - Investing.com
Castle Biosciences (CSTL) CEO pre-planned sale of 9,836 shares after option exercise - Stock Titan
Strong 2025 revenue and governance focus in Castle Biosciences (CSTL) proxy - Stock Titan
Castle Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer MAETZOLD DEREK J - Moomoo
Castle Biosciences, Inc. (CSTL) stock price, news, quote and history - Yahoo Finance Singapore
Castle Biosciences, Inc. (CSTL) Stock Price, News, Quote & History - Yahoo! Finance Canada
AI Stocks: Can Castle Biosciences Inc maintain its current growth rate2026 Highlights & Daily Price Action Insights - baoquankhu1.vn
How Revenue Assumptions Are Rewriting The Story For Castle Biosciences (CSTL) - Yahoo Finance
CSTL PE Ratio & Valuation, Is CSTL Overvalued - Intellectia AI
CSTL SEC FilingsCastle Biosciences 10-K, 10-Q, 8-K Forms - Stock Titan
1.63%
0.34%
자본화:
|
볼륨(24시간):